Showing results (1-10 of 27) with videos related to
Sort By:
Pageof 3
Idcases|August 12, 2021
Immune thrombocytopenia associated with Pfizer-BioNTech's BNT162b2 mRNA COVID-19 vaccineHiroaki Akiyama, Seiji Kakiuchi, Junpei Rikitake, et al.Cancer Science|July 28, 2016
Small-molecule Hedgehog inhibitor attenuates the leukemia-initiation potential of acute myeloid leukemia cellsNobuaki Fukushima, Yosuke Minami, Seiji Kakiuchi, et al.The American Journal of Case Reports|September 21, 2020
Autoimmune Myelofibrosis in Sjögren's Syndrome: Report of a CaseSeiji Kakiuchi, Ikumi Takagi, Hiroaki Akiyama, et al.[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|March 29, 2023
[Autoimmune hemolytic anemia complicated with acute kidney injury and tubulopathy due to hemoglobin casts]Junpei Rikitake, Seiji Kakiuchi, Ikumi Takagi, et al.No Shinkei Geka. Neurological Surgery|June 13, 2014
[A case of possible immunoglobulin G4-related disease (IgG4-RD) with retroperitoneal fibrosis and central diabetes insipidus due to infundibulohypophysitis]Jun Tanaka, Atsushi Arai, Shigeto Hayashi, et al.Frontiers in Medicine|January 11, 2021
Case Report: Composite Angioimmunoblastic T-Cell Lymphoma and Epstein-Barr Virus-Positive B-Cell Lymphoproliferative Disorder as Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative DisordersSeiji Kakiuchi, Kimikazu Yakushijin, Ikumi Takagi, et al.Journal of Oleo Science|September 28, 2007
Citrus auraptene reduces Helicobacter pylori colonization of glandular stomach lesions in Mongolian gerbilsKoichi Takeda, Hirotoshi Utsunomiya, Seiji Kakiuchi, et al.Internal Medicine (Tokyo, Japan)|October 19, 2022
Cytomegalovirus Oophoritis Mimicking Burkitt's Lymphoma Recurrence: A Case Report and Literature ReviewIkumi Takagi, Hiroaki Akiyama, Hiroyuki Matsuba, et al.International Journal of Molecular Sciences|March 2, 2017
NANOG Expression as a Responsive Biomarker during Treatment with Hedgehog Signal Inhibitor in Acute Myeloid LeukemiaSeiji Kakiuchi, Yosuke Minami, Yoshiharu Miyata, et al.[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|February 8, 2021
[Successful treatment with ponatinib in combination with hyper-CVAD for chronic myeloid leukemia in the lymphoid blastic phase]Seiji Kakiuchi, Junpei Rikitake, Hiroki Kitazawa, et al.Pageof 3